William J. Newell

2019

In 2019, William J. Newell earned a total compensation of $3.8M as Chief Executive Officer at SUTRO BIOPHARMA, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$223,425
Option Awards$3,097,200
Salary$496,500
Total$3,817,125

Newell received $3.1M in option awards, accounting for 81% of the total pay in 2019.

Newell also received $223.4K in non-equity incentive plan and $496.5K in salary.

Rankings

In 2019, William J. Newell's compensation ranked 3,143rd out of 13,971 executives tracked by ExecPay. In other words, Newell earned more than 77.5% of executives.

ClassificationRankingPercentile
All
3,143
out of 13,971
78th
Division
Manufacturing
1,136
out of 5,701
80th
Major group
Chemicals And Allied Products
386
out of 2,200
83rd
Industry group
Drugs
317
out of 1,886
83rd
Industry
Biological Products, Except Diagnostic Substances
74
out of 389
81st
Source: SEC filing on April 24, 2020.

Newell's colleagues

We found four more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2019.

2019

Trevor Hallam

SUTRO BIOPHARMA

Chief Scientific Officer

2019

Arturo Molina

SUTRO BIOPHARMA

Chief Medical Officer

2019

Arturo FACP

SUTRO BIOPHARMA

Chief Medical Officer

2019

Linda Fitzpatrick

SUTRO BIOPHARMA

Chief People and Communications Officer

News

In-depth

You may also like